FDAFDA · Food and drugs·Recall number D-0218-2026
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13.
Published December 17, 2025 · Recall initiated: October 24, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed stability specifications: Out of specification for hardness test
What to do
Voluntary: Firm initiated
Recall details
- Brand
- LANTHANUM CARBONATE
- Manufacturer
- Cipla USA, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0376282478135
- Lot
- Lot# NB240314, exp 12/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.